Global Oral Cholera Vaccine 麻豆原创 Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Publication ID:

PB506246837

Publication Date:

June 21, 2024

Pages:

126

Publisher:

MRRPB5

Countries:

Global [1]

USD 5,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Oral Cholera Vaccine market is projected to reach US$ 146.3 million by 2030 from an estimated US$ 95 million in 2024, at a CAGR of 7.5% during 2024 and 2030.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Cholera Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Oral Cholera Vaccine.
The Oral Cholera Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Cholera Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Cholera Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
麻豆原创 Segmentation
By Company
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
Segment by Type
Euvichol-Plus
DUKORAL
Shanchol
Others
Segment by Application
Preventive Campaigns
Outbreak Response
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oral Cholera Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Oral Cholera Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Cholera Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Oral Cholera Vaccine Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Oral Cholera Vaccine 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Euvichol-Plus
1.2.3 DUKORAL
1.2.4 Shanchol
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Oral Cholera Vaccine 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Preventive Campaigns
1.3.3 Outbreak Response
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Cholera Vaccine 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Oral Cholera Vaccine Revenue 2019-2030
2.1.2 Global Oral Cholera Vaccine Sales 2019-2030
2.2 Oral Cholera Vaccine 麻豆原创 Size by Region: 2023 Versus 2030
2.3 Oral Cholera Vaccine Sales by Region (2019-2030)
2.3.1 Global Oral Cholera Vaccine Sales by Region: 2019-2024
2.3.2 Global Oral Cholera Vaccine Sales Forecast by Region (2025-2030)
2.3.3 Global Oral Cholera Vaccine Sales 麻豆原创 Share by Region (2019-2030)
2.4 Oral Cholera Vaccine 麻豆原创 Estimates and Projections by Region (2025-2030)
2.4.1 Global Oral Cholera Vaccine Revenue by Region: 2019-2024
2.4.2 Global Oral Cholera Vaccine Revenue Forecast by Region (2025-2030)
2.4.3 Global Oral Cholera Vaccine Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Oral Cholera Vaccine by Manufacturers
3.1 Global Top Oral Cholera Vaccine Manufacturers by Sales
3.1.1 Global Oral Cholera Vaccine Sales by Manufacturer (2019-2024)
3.1.2 Global Oral Cholera Vaccine Sales 麻豆原创 Share by Manufacturer (2019-2024)
3.2 Global Top Oral Cholera Vaccine Manufacturers by Revenue
3.2.1 Global Oral Cholera Vaccine Revenue by Manufacturer (2019-2024)
3.2.2 Global Oral Cholera Vaccine Revenue Share by Manufacturer (2019-2024)
3.3 Global Oral Cholera Vaccine Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Oral Cholera Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Oral Cholera Vaccine 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Oral Cholera Vaccine 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Oral Cholera Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Oral Cholera Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Oral Cholera Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Oral Cholera Vaccine 麻豆原创
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 PaxVax
4.1.1 PaxVax Company Information
4.1.2 PaxVax Description, Business Overview
4.1.3 PaxVax Oral Cholera Vaccine Products Offered
4.1.4 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.5 PaxVax Oral Cholera Vaccine Sales by Product in 2023
4.1.6 PaxVax Oral Cholera Vaccine Sales by Application in 2023
4.1.7 PaxVax Oral Cholera Vaccine Sales by Geographic Area in 2023
4.1.8 PaxVax Recent Developments
4.2 Sanofi
4.2.1 Sanofi Company Information
4.2.2 Sanofi Description, Business Overview
4.2.3 Sanofi Oral Cholera Vaccine Products Offered
4.2.4 Sanofi Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Sanofi Oral Cholera Vaccine Sales by Product in 2023
4.2.6 Sanofi Oral Cholera Vaccine Sales by Application in 2023
4.2.7 Sanofi Oral Cholera Vaccine Sales by Geographic Area in 2023
4.2.8 Sanofi Recent Developments
4.3 Valneva
4.3.1 Valneva Company Information
4.3.2 Valneva Description, Business Overview
4.3.3 Valneva Oral Cholera Vaccine Products Offered
4.3.4 Valneva Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Valneva Oral Cholera Vaccine Sales by Product in 2023
4.3.6 Valneva Oral Cholera Vaccine Sales by Application in 2023
4.3.7 Valneva Oral Cholera Vaccine Sales by Geographic Area in 2023
4.3.8 Valneva Recent Developments
4.4 EuBiologics
4.4.1 EuBiologics Company Information
4.4.2 EuBiologics Description, Business Overview
4.4.3 EuBiologics Oral Cholera Vaccine Products Offered
4.4.4 EuBiologics Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.5 EuBiologics Oral Cholera Vaccine Sales by Product in 2023
4.4.6 EuBiologics Oral Cholera Vaccine Sales by Application in 2023
4.4.7 EuBiologics Oral Cholera Vaccine Sales by Geographic Area in 2023
4.4.8 EuBiologics Recent Developments
4.5 United Biotech
4.5.1 United Biotech Company Information
4.5.2 United Biotech Description, Business Overview
4.5.3 United Biotech Oral Cholera Vaccine Products Offered
4.5.4 United Biotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.5 United Biotech Oral Cholera Vaccine Sales by Product in 2023
4.5.6 United Biotech Oral Cholera Vaccine Sales by Application in 2023
4.5.7 United Biotech Oral Cholera Vaccine Sales by Geographic Area in 2023
4.5.8 United Biotech Recent Developments
4.6 Vabiotech
4.6.1 Vabiotech Company Information
4.6.2 Vabiotech Description, Business Overview
4.6.3 Vabiotech Oral Cholera Vaccine Products Offered
4.6.4 Vabiotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Vabiotech Oral Cholera Vaccine Sales by Product in 2023
4.6.6 Vabiotech Oral Cholera Vaccine Sales by Application in 2023
4.6.7 Vabiotech Oral Cholera Vaccine Sales by Geographic Area in 2023
4.6.8 Vabiotech Recent Development
4.7 PaxVax
4.7.1 PaxVax Company Information
4.7.2 PaxVax Description, Business Overview
4.7.3 PaxVax Oral Cholera Vaccine Products Offered
4.7.4 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.5 PaxVax Oral Cholera Vaccine Sales by Product in 2023
4.7.6 PaxVax Oral Cholera Vaccine Sales by Application in 2023
4.7.7 PaxVax Oral Cholera Vaccine Sales by Geographic Area in 2023
4.7.8 PaxVax Recent Development
5 Breakdown Data by Type
5.1 Global Oral Cholera Vaccine Sales by Type (2019-2030)
5.1.1 Global Oral Cholera Vaccine Sales by Type (2019-2024)
5.1.2 Global Oral Cholera Vaccine Sales Forecast by Type (2025-2030)
5.1.3 Global Oral Cholera Vaccine Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Oral Cholera Vaccine Revenue Forecast by Type (2019-2030)
5.2.1 Global Oral Cholera Vaccine Revenue by Type (2019-2024)
5.2.2 Global Oral Cholera Vaccine Revenue Forecast by Type (2025-2030)
5.2.3 Global Oral Cholera Vaccine Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Oral Cholera Vaccine Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Oral Cholera Vaccine Sales by Application (2019-2030)
6.1.1 Global Oral Cholera Vaccine Sales by Application (2019-2024)
6.1.2 Global Oral Cholera Vaccine Sales Forecast by Application (2025-2030)
6.1.3 Global Oral Cholera Vaccine Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Oral Cholera Vaccine Revenue Forecast by Application (2019-2030)
6.2.1 Global Oral Cholera Vaccine Revenue by Application (2019-2024)
6.2.2 Global Oral Cholera Vaccine Revenue Forecast by Application (2025-2030)
6.2.3 Global Oral Cholera Vaccine Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Oral Cholera Vaccine Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Oral Cholera Vaccine 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Oral Cholera Vaccine 麻豆原创 Facts & Figures by Country
7.2.1 North America Oral Cholera Vaccine Sales by Country (2019-2030)
7.2.2 North America Oral Cholera Vaccine Revenue by Country (2019-2030)
7.3 North America Oral Cholera Vaccine Sales by Type (2019-2024)
7.4 North America Oral Cholera Vaccine Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Oral Cholera Vaccine 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Oral Cholera Vaccine 麻豆原创 Facts & Figures by Region
8.2.1 Asia-Pacific Oral Cholera Vaccine Sales by Region (2019-2030)
8.2.2 Asia-Pacific Oral Cholera Vaccine Revenue by Region (2019-2030)
8.3 Asia-Pacific Oral Cholera Vaccine Sales by Type (2019-2024)
8.4 Asia-Pacific Oral Cholera Vaccine Sales by Application (2019-2024)
9 Europe
9.1 Europe Oral Cholera Vaccine 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Oral Cholera Vaccine 麻豆原创 Facts & Figures by Country
9.2.1 Europe Oral Cholera Vaccine Sales by Country (2019-2030)
9.2.2 Europe Oral Cholera Vaccine Revenue by Country (2019-2030)
9.3 Europe Oral Cholera Vaccine Sales by Type (2019-2024)
9.4 Europe Oral Cholera Vaccine Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Oral Cholera Vaccine 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Oral Cholera Vaccine 麻豆原创 Facts & Figures by Country
10.2.1 Latin America Oral Cholera Vaccine Sales by Country (2019-2030)
10.2.2 Latin America Oral Cholera Vaccine Revenue by Country (2019-2030)
10.3 Latin America Oral Cholera Vaccine Sales by Type (2019-2024)
10.4 Latin America Oral Cholera Vaccine Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Oral Cholera Vaccine 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Oral Cholera Vaccine 麻豆原创 Facts & Figures by Country
11.2.1 Middle East and Africa Oral Cholera Vaccine Sales by Country (2019-2030)
11.2.2 Middle East and Africa Oral Cholera Vaccine Revenue by Country (2019-2030)
11.3 Middle East and Africa Oral Cholera Vaccine Sales by Type (2019-2024)
11.4 Middle East and Africa Oral Cholera Vaccine Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Oral Cholera Vaccine Supply Chain Analysis
12.2 Oral Cholera Vaccine Key Raw Materials and Upstream Suppliers
12.3 Oral Cholera Vaccine Clients Analysis
12.4 Oral Cholera Vaccine Sales Channel and Sales Model Analysis
12.4.1 Oral Cholera Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Oral Cholera Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Oral Cholera Vaccine Distributors
13 麻豆原创 Dynamics
13.1 Oral Cholera Vaccine Industry Trends
13.2 Oral Cholera Vaccine 麻豆原创 Drivers
13.3 Oral Cholera Vaccine 麻豆原创 Challenges
13.4 Oral Cholera Vaccine 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.